Justin Sullivan/Getty Images News Baird analysts evaluated the short interest levels across stocks in the fashion and wellness industry, as…
Read More »Baird
Shidlovski Baird said it thinks recent weakness in Ocular Therapeutix (NASDAQ:OCUL) shares is “overdone” and remains bullish on the company’s…
Read More »peterschreiber.media Baird has initiated coverage of Nuvalent (NASDAQ:NUVL) with an outperform rating, citing the potential of its two lead assets,…
Read More »sutthirat sutthisumdang Baird has chosen Alcon (NYSE:ALC), Stryker (NYSE:SYK), The Cooper Companies (NASDAQ:COO), Axonics (NASDAQ:AXNX) and Boston Scientific (NYSE:BSX) as…
Read More »